Abstract
The effect of blocking delta opioid receptors on alcohol aversion was examined in female alcohol-preferring (P) rats using a conditioned taste aversion (CTA) paradigm. In experiment 1, alcohol naive P rats were given i.p injections of 0.5, 1.0 or 1.5 g alcohol/kg BW or saline, paired with consumption of a banana-flavored solution during 5 conditioning trials. Alcohol in a dose of 0.5 g/kg was not aversive while the two higher doses (1.0 and 1.5 g/kg) were both aversive in the CTA paradigm. In experiment 2, the effect of the selective delta opioid receptor antagonist, naltrindole (NTI), on alcohol aversion was examined. Rats were pretreated with NTI in doses of 2.5, 5.0, 10.0 or 20.0 mg/kg before conditioning using the nonaversive dose of alcohol from Experiment 1. As in experiment 1, the 0.5 g/kg dose of alcohol did not produce a CTA. Administration of NTI alone in doses of 2.5, 5.0 or 10.0 mg/kg did not produce a CTA. However, when the nonaversive dose of alcohol (0.5 g/kg) was combined with NTI in a dose of either 5.0 or 10.0 mg/kg, an aversion to alcohol was seen. The highest dose of NTI (20 mg/kg) produced a CTA when given either alone and in combination with alcohol. The results indicate that blocking the action of opioid peptides at the deltaopioid receptor can make a nonaversive dose of alcohol aversive which suggests that opioid peptides, acting via thedelta opioid receptor, play an important role in regulating alcohol aversion.
Footnotes
-
Send reprint requests to: Dr. J. C. Froehlich, Indiana University School of Medicine, Department of Medicine, Emerson Hall 421, 545 Barnhill Drive, Indianapolis, IN 46202-5124.
-
↵1 This study was supported by Grants AA10709 and AA08312 from the NIH/NIAAA (J.C.F.).
- Abbreviations:
- CTA
- conditioned taste aversion
- NTI
- naltrindole
- BAC
- blood alcohol concentration
- P rats
- alcohol-preferring rats
- ANOVA
- analysis of variance
- CS
- conditioned stimulus
- i.p.
- intraperitoneal
- i.g.
- intragastric
- Received March 2, 1998.
- Accepted May 2, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|